Clinical Trial Update: Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating chidamide in combination with decitabine for relapsed/refractory non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Decitabine (Decitabine)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Non Hodgkin Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN